An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma (??)

Grant type:
NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
Researchers:
Funded by:
Commonwealth Department of Health